Navigation Links
BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
Date:5/21/2012

VIENNA, May 21, 2012 /PRNewswire/ --

Austrian BIOCRATES Life Sciences AG, prime developer of state-of-the-art metabolite biomarker panels, is about to launch new editions of two of its well-established research kit products -AbsoluteIDQ® p180 and p150. Originally developed for use with the AB Sciex mass spectrometers, both kits are now available for Waters Xevo® TQ MS systems,  greatly increasing sample throughput and accelerating up analytical processes.

AbsoluteIDQ® p180 Kit-Waters Xevo® TQ MS edition
Now also running on the ACQUITY UPLC® system by Waters, the new edition of the AbsoluteIDQ  p180 Kit speeds up your research, requiring only 16 hours of measurement time compared with 32 hours for conventional high performance liquid chromatography (HPLC). The Waters UPLC® technology was created especially for scientists who seek a reliable technology that simultaneously improves laboratory productivity, efficiency, and throughput.

Quantifying more than 180 metabolites from key metabolic pathways, the AbsoluteIDQ p180 Kit delivers the widest range of metabolomic information available from a single targeted assay. Analyzed metabolite classes include acylcarnitines, amino acids and biogenic amines, hexose, and sphingo- and glycerophospholipids.

AbsoluteIDQ® p150 Kit-Waters Xevo® TQ MS edition
Also now available for Waters Xevo TQ mass spectrometers is the AbsoluteIDQ p150 Kit, which identifies and quantifies 158 metabolites from 4 compound classes using a FIA-MS/MS method.

Both kits feature the proprietary MetIDQ™ software for the automated calculation of metabolite concentrations, require only small sample volumes of 10 µL, and are suitable for use with a wide range of biological samples.

About BIOCRATES
BIOCRATES Life Sciences AG is a leading biotechnology company focused on biomarker discovery and the development of  MS-based standardized metabolomics kits as well as in vitro diagnostics (IVDs). Please visit us at http://www.biocrates.com.

For questions: Michael Leitner, Public Health PR
Tel.: +43-1-602-05-30-92, e-mail: michael.leitner@publichealth.at


'/>"/>
SOURCE Biocrates Life Sciences AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
2. Egalet to Present at Life Sciences Europe Conference
3. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
4. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
5. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
10. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... --> --> This press release is ... --> Japan .  --> A separate press release has ... Shire continues to strengthen its presence ... Shire continues to strengthen its presence in ... continues to strengthen its presence in ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... YORK , Feb. 10, 2016 Immune ... biopharmaceutical company, announced today that it has filed a ... Leukemia and other cancers. --> ... treating cancer by administration of Ceplene (histamine dihydrochloride) in ... provides methods of predicting the efficacy of Ceplene and ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... From March 4 through ... Dermatology Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. ... the condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company ...
(Date:2/11/2016)... Diego, CA (PRWEB) , ... February 11, 2016 , ... ... which was held in San Diego, CA, on February 6th & 7th, 2016 according ... combine for those who were not invited to the NFL’s combine in Indianapolis,” says ...
(Date:2/11/2016)... ... 11, 2016 , ... The book, “Computers Should Just Work!”, provides a basic, ... your IT consultant before signing a contract and how to spot an incompetent or ... relying heavily on e-mail and technology, it’s more important than ever to make sure ...
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of ... Round Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian ... Billy Cundiff. , “We are honored to support a promising young investigator from Dr. ...
(Date:2/10/2016)... Culver City, California (PRWEB) , ... February 10, ... ... Molecular Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will ... The theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will ...
Breaking Medicine News(10 mins):